Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension

Summary

Open-label pilot study of early inhaled nitric oxide (iNO) for patients developing de novo pulmonary hypertension during Acute Respiratory Distress Syndrome (ARDS.) The study aims to determine whether iNO has possible hemodynamic and clinical benefits when given early in the course of ARDS to patients with evidence of elevated pulmonary artery pressure.

Timeline

Start

2024-02

Primary completion

2026-02

Completion

2026-02

Drugs

Indications